Latest News about XBI
Recent news which mentions XBI
From MarketWatch
Short Sellers Still Targeting Retail, Biotech ETFs
February 18, 2021
From Benzinga
3 Biotech Stocks to Buy As Things Heat Up for the Sector
February 18, 2021
From InvestorPlace
Here’s one strategist’s road map for investors who want to dodge ‘stonks’ and ride inflation
February 17, 2021
From MarketWatch
How To Improve Your Investment Future In Just 10 Minutes
February 10, 2021
From Benzinga
Short-Sellers Have These 3 ETFs in Their Sights
February 03, 2021
From Motley Fool
Charting a bullish February start: S&P 500 spikes from major support
February 02, 2021
From MarketWatch
Is Gilead Sciences Stock a Buy?
January 27, 2021
From Motley Fool
Why I'm Betting Big on This 1 Megatrend
January 25, 2021
From Motley Fool
Fear of new virus variant pushes U.S. toward more genomic sequencing
January 15, 2021
From MarketWatch
3 Top Biotech Picks for 2021
January 10, 2021
From Motley Fool
From MarketWatch
How to make money in 2021 — follow these three stock market takeaways from last year
January 06, 2021
From MarketWatch
Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021
December 31, 2020
From ETF Trends
Health experts slam delayed vaccine rollout in U.S. as early effort falls far short of expectations
December 29, 2020
From MarketWatch
Arcturus Therapeutics shares slide 37% in premarket after COVID vaccine data are deemed ‘underwhelming’
December 29, 2020
From MarketWatch
Myovant shares soar 27% on news of Pfizer prostate cancer drug collaboration worth up to $4.2 billion
December 28, 2020
From MarketWatch
ETF Wrap: Marcia, Marcia, Marcia!
December 17, 2020
From MarketWatch
As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally
December 03, 2020
From ETF Trends
ETF Wrap: Size doesn’t matter
December 03, 2020
From MarketWatch
How Will Vaccine Arrivals Affect Biotech ETFs?
November 30, 2020
From ETF Trends
Biotech ETFs Remain Hot As Investors Await Upcoming Vaccine
November 27, 2020
From ETF Trends
Biotech ETFs Poised for Gains after Moderna Vaccine News
November 16, 2020
From ETF Trends
Moderna’s COVID-19 vaccine candidate achieves 94.5% efficacy in late-stage trial, sparking market rally
November 16, 2020
From MarketWatch
Will Moderna Vaccine News Boost Biotech ETFs?
November 12, 2020
From ETF Trends
These 23 stocks and ETFs will benefit from the 6 most important changes for stock-market investors under Biden
November 11, 2020
From MarketWatch
GW Pharma shares rally on earnings and news of late-stage trial of cannabis-based treatment for MS patients
November 03, 2020
From MarketWatch
Can’t Get Enough Biotech Exposure in Your Portfolio?
October 29, 2020
From ETF Trends
ETF Wrap: Rise of the robots, and leveraged ETFs are here to stay
October 29, 2020
From MarketWatch
America’s ‘Financial First Responders’ Examine the 2020 Election
October 21, 2020
From ETF Trends
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.